While the United Kingdom feted President Trump in his second state visit, GSK said Wednesday it will spend $30 billion over the next five years to build new manufacturing and research facilities ...
Miels succeeded Emma Walmsley to become GSK’s new CEO at the beginning of 2026, inheriting the role as GSK posted what he ...
SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics (207940.KS), opens new tab said on Monday it is acquiring its first U.S. drug production facility from GSK (GSK.L), opens new tab for $280 ...
Samsung Biologics will acquire a drug manufacturing facility in the United States from GlaxoSmithKline (GSK) for $280 million, marking its first production foothold in the country as it seeks to ...
GSK plc (NYSE:GSK) on Wednesday announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The update includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results